Your browser doesn't support javascript.
loading
Cellular and Molecular Aspects of Managing Familial Hypercholesterolemia: Recent and Emerging Therapeutic Approaches.
Taheri, Forough; Taghizadeh, Eskandar; Baniamerian, Fatemeh; Rostami, Daryoush; Rozeian, Ahmad; Mohammad Gheibi Hayat, Seyed; Jamialahmadi, Tannaz; Reiner, Zeljko; Sahebkar, Amirhossein.
Afiliación
  • Taheri F; Department of Genetics, Sharekord Branch, Islamic Azad University, Sharekord, Iran.
  • Taghizadeh E; Department of Medical Genetics, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Baniamerian F; Department of Genetics, Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
  • Rostami D; Department of Genetics, Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
  • Rozeian A; Department of Anesthesia, School of Paramedical Sciences, Zabol University of Medical Sciences, Zabol, Iran.
  • Mohammad Gheibi Hayat S; Department of Genetics, Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
  • Jamialahmadi T; Department of Medical Genetics, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Reiner Z; Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Sahebkar A; Department of Internal Medicine, University Hospital Center Zagreb, School of Medicine University of Zagreb, Croatia.
Endocr Metab Immune Disord Drug Targets ; 22(10): 1018-1028, 2022.
Article en En | MEDLINE | ID: mdl-35532248
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proproteína Convertasa 9 / Hiperlipoproteinemia Tipo II Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Endocr Metab Immune Disord Drug Targets Asunto de la revista: ALERGIA E IMUNOLOGIA / ENDOCRINOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Irán
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proproteína Convertasa 9 / Hiperlipoproteinemia Tipo II Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Endocr Metab Immune Disord Drug Targets Asunto de la revista: ALERGIA E IMUNOLOGIA / ENDOCRINOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Irán